Clin2
NCT07685938Possibly a fitNot yet recruiting

Medicines to prevent heart damage from radiation

Chest Wall TumorBreast CancerLung CancerEsophageal CancerMediastinal CancersSpine MetastasesSpinal TumorThoracic Cancer

Part of Brain & nervous system, Cancer, Digestive system, Heart & circulation, Lungs & breathing, Skin clinical trials.

This trial tests whether common heart medicines (statins or ACE-inhibitors) can protect the heart during cancer radiation therapy. It is for adults who are about to start chest radiation and have not taken these drugs before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You are willing to give blood samples for the study
  • You are not already taking a statin or ACE-inhibitor
  • You do not have low blood pressure (hypotension)
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06986291Not yet recruiting
Heart side effects from radiation for certain cancers

This trial looks at how radiation for lung, esophageal, or breast cancer affects the heart. It may help doctors reduce heart damage in future patients.

Dresden, Germany
NCT06897189Not yet recruiting
Safer radiation for chest tumors with wearable heart monitoring

This trial is testing whether a lower radiation dose and a wearable heart monitor can reduce the risk of heart rhythm problems in people receiving chest radiation for cancer. It may help those at moderate-to-high risk of heart side effects from treatment.

Seoul
NCT07703033Recruiting
Heart Impact Study for Breast Cancer Radiotherapy

This study looks at how information about the heart may affect treatment decisions for people receiving radiation therapy for breast cancer. It aims to help reduce heart-related side effects from treatment.

Copenhagen
NCT07254221Not yet recruiting· Phase 4
Rosuvastatin to protect heart during breast cancer chemo

This trial tests if taking rosuvastatin (a cholesterol-lowering pill) can help prevent heart damage from anthracycline chemotherapy in women with breast cancer. If you are about to start this type of chemo and have not used statins before, you may qualify.

Shiraz, Fars
NCT06410300Recruiting
Heart and lung monitoring during lung cancer radiation and immunotherapy

This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.

Columbia, Missouri
NCT07669493Recruiting
Heart safety during chest radiation for cancer patients

This study looks at how chest radiation affects heart function and the immune system, and whether it is safe in people with lung, esophageal, breast, or thymus cancer who have not had chest radiation before.

Shijiazhuang, Hebei

Hear when a new Chest Wall Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.